<SEC-DOCUMENT>0000950170-24-100026-index.html : 20240823
<SEC-HEADER>0000950170-24-100026.hdr.sgml : 20240823
<ACCEPTANCE-DATETIME>20240823085439
ACCESSION NUMBER:		0000950170-24-100026
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240823
DATE AS OF CHANGE:		20240823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virax Biolabs Group Ltd
		CENTRAL INDEX KEY:			0001885827
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275893
		FILM NUMBER:		241233618

	BUSINESS ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH
		BUSINESS PHONE:		44 020 7788 7414

	MAIL ADDRESS:	
		STREET 1:		BIOCITY GLASGOW
		STREET 2:		BO'NESS ROAD, NEWHOUSE
		CITY:			LANARKSHIRE
		STATE:			X0
		ZIP:			ML1 5UH

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Virax Biolabs (Cayman) Ltd
		DATE OF NAME CHANGE:	20210930
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>pro_sup_august_2024.htm
<DESCRIPTION>424B5
<TEXT>
Document 1 - file: pro_sup_august_2024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img248689593_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img248689593_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img248689593_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img248689593_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img248689593_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: img248689593_2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img248689593_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img248689593_3.jpg

</DOCUMENT>
</SEC-DOCUMENT>